PAR-21-237 - NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 3
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS) | NOT-HL-24-018 | NHLBI , NINDS , OD , ORWH | Aug 13, 2024 | Jan 8, 2028 | UG3/UH3, R01, K08, K99/R00, K01, R21, K25, K23 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI) for Efficacy Trials of Epidural Stimulation for Spinal Cord Injury | NOT-NS-23-038 | NINDS | Dec 15, 2022 | Oct 11, 2023 | UG3/UH3 |
Notice of Special Interest (NOSI): Research in the Emergency Setting | NOT-NS-20-005 | NINDS NCI NIDA NHLBI NIDCD NIAAA NICHD NIA NIGMS NEI NIMHD NIMH | Sep 8, 2020 | Sep 8, 2022 | R01, R21, R03, K01, K99/R00, K08, K23, R13, R43/R44, R41/R42, P01, U01, R34, R35, RM1 |